These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 10951228)

  • 1. Death receptors in cutaneous biology and disease.
    Wehrli P; Viard I; Bullani R; Tschopp J; French LE
    J Invest Dermatol; 2000 Aug; 115(2):141-8. PubMed ID: 10951228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fas-mediated cell death in toxic epidermal necrolysis and graft-versus-host disease: potential for therapeutic inhibition.
    French LE; Tschopp J
    Schweiz Med Wochenschr; 2000 Nov; 130(44):1656-61. PubMed ID: 11103436
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein-based therapeutic approaches targeting death receptors.
    French LE; Tschopp J
    Cell Death Differ; 2003 Jan; 10(1):117-23. PubMed ID: 12655300
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Death receptors and apoptosis.
    Contassot E; Gaide O; French LE
    Dermatol Clin; 2007 Oct; 25(4):487-501, vii. PubMed ID: 17903608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Insulin-like growth factor-I protects colon cancer cells from death factor-induced apoptosis by potentiating tumor necrosis factor alpha-induced mitogen-activated protein kinase and nuclear factor kappaB signaling pathways.
    Remacle-Bonnet MM; Garrouste FL; Heller S; André F; Marvaldi JL; Pommier GJ
    Cancer Res; 2000 Apr; 60(7):2007-17. PubMed ID: 10766192
    [TBL] [Abstract][Full Text] [Related]  

  • 6. FasL and TRAIL induce epidermal apoptosis and skin ulceration upon exposure to Leishmania major.
    Eidsmo L; Fluur C; Rethi B; Eriksson Ygberg S; Ruffin N; De Milito A; Akuffo H; Chiodi F
    Am J Pathol; 2007 Jan; 170(1):227-39. PubMed ID: 17200196
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Role of NF-kappaB activity in apoptotic response of keratinocytes mediated by interferon-gamma, tumor necrosis factor-alpha, and tumor-necrosis-factor-related apoptosis-inducing ligand.
    Qin JZ; Bacon P; Chaturvedi V; Nickoloff BJ
    J Invest Dermatol; 2001 Oct; 117(4):898-907. PubMed ID: 11676830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Survivin: a dual player in healthy and diseased skin.
    Dallaglio K; Marconi A; Pincelli C
    J Invest Dermatol; 2012 Jan; 132(1):18-27. PubMed ID: 21900948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ultraviolet light-induced immune tolerance is mediated via the Fas/Fas-ligand system.
    Schwarz A; Grabbe S; Grosse-Heitmeyer K; Roters B; Riemann H; Luger TA; Trinchieri G; Schwarz T
    J Immunol; 1998 May; 160(9):4262-70. PubMed ID: 9574528
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structural determinants of DISC function: new insights into death receptor-mediated apoptosis signalling.
    Sessler T; Healy S; Samali A; Szegezdi E
    Pharmacol Ther; 2013 Nov; 140(2):186-99. PubMed ID: 23845861
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of small molecules that sensitize resistant tumor cells to tumor necrosis factor-family death receptors.
    Schimmer AD; Thomas MP; Hurren R; Gronda M; Pellecchia M; Pond GR; Konopleva M; Gurfinkel D; Mawji IA; Brown E; Reed JC
    Cancer Res; 2006 Feb; 66(4):2367-75. PubMed ID: 16489043
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Messengers of cell death: apoptotic signaling in health and disease.
    Rossi D; Gaidano G
    Haematologica; 2003 Feb; 88(2):212-8. PubMed ID: 12604411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The glucocorticoid-induced TNF receptor-related protein (GITR)-GITR ligand pathway acts as a mediator of cutaneous dendritic cell migration and promotes T cell-mediated acquired immunity.
    Kamimura Y; Iwai H; Piao J; Hashiguchi M; Azuma M
    J Immunol; 2009 Mar; 182(5):2708-16. PubMed ID: 19234165
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Abnormal Fas/FasL and caspase-3-mediated apoptotic signaling pathways of T lymphocyte subset in patients with systemic lupus erythematosus.
    Xue C; Lan-Lan W; Bei C; Jie C; Wei-Hua F
    Cell Immunol; 2006 Feb; 239(2):121-8. PubMed ID: 16808908
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Segregation of APO-1/Fas antigen- and tumor necrosis factor receptor-mediated apoptosis.
    Grell M; Krammer PH; Scheurich P
    Eur J Immunol; 1994 Oct; 24(10):2563-6. PubMed ID: 7523147
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeting death receptors in bladder, prostate and renal cancer.
    O'Kane HF; Watson CJ; Johnston SR; Petak I; Watson RW; Williamson KE
    J Urol; 2006 Feb; 175(2):432-8. PubMed ID: 16406966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Exploring cell death mechanisms by analyzing signaling cascades of the TNF/NGF receptor family.
    Wallach D; Boldin M; Goncharov T; Goltsev Y; Mett I; Malinin N; Adar R; Kovalenko A; Varfolomeev E
    Behring Inst Mitt; 1996 Oct; (97):144-55. PubMed ID: 8950472
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Unique resistance of breast carcinoma cell line T47D to TRAIL but not anti-Fas is linked to p43cFLIP(L).
    Guseva NV; Rokhlin OW; Taghiyev AF; Cohen MB
    Breast Cancer Res Treat; 2008 Feb; 107(3):349-57. PubMed ID: 17453339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pathogenesis and recent therapeutic trends in Stevens-Johnson syndrome and toxic epidermal necrolysis.
    Khalili B; Bahna SL
    Ann Allergy Asthma Immunol; 2006 Sep; 97(3):272-80; quiz 281-3, 320. PubMed ID: 17042130
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potentiation of Fas-mediated apoptosis of murine granulosa cells by interferon-gamma, tumor necrosis factor-alpha, and cycloheximide.
    Quirk SM; Porter DA; Huber SC; Cowan RG
    Endocrinology; 1998 Dec; 139(12):4860-9. PubMed ID: 9832422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.